Peer-reviewed articleOpen access

Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Mitchell JM iD, Ot'alora G M iD, van der Kolk B, Shannon S iD, Bogenschutz M iD, Gelfand Y, Paleos C, Nicholas CR, Quevedo S, Balliett B, Hamilton S, Mithoefer M iD, Kleiman S, Parker-Guilbert K, Tzarfaty K, Harrison C, de Boer A, Doblin R, Yazar-Klosinski B

Nature medicineNov 1, 2024License: open accessUnited States, Israel1 citationsDOI: 10.1038/s41591-024-03331-w

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

MDMAPTSD

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleMDMA

Aesthetic mediation and lateral agency: Rethinking trauma and drug consumption in 'crisis ordinariness'.

Fomiatti R, Keane H, Nourse G +4

Europe PMC2026

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023

ArticleMDMA

Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence.

Sippel LM, Hamblen JL, Kelmendi B +10

Europe PMC2024